ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 226

Biopsy Proven Giant Cell Arteritis in African Descent Populations: Incidence and Characteristics in Martinique, French West Indies

Florence Moinet1, Vincent Molinie2, Katlyne Polomat1, Harold Merle3, Marie Blettery4, Lauren Brunier-Agot4, Michel DeBandt4 and Christophe Deligny1, 1Internal medicine, National referral Center for Lupus, Antiphospholipid syndrome and other rare auto-immune diseases, Hopital Pierre Zobda Quitman, CHU de Martinique, Fort de France, Martinique, 2Pathology unit, Hopital Pierre Zobda Quitman, CHU de Martinique, Fort de France, Martinique, 3Ophthalmology, Hopital Pierre Zobda Quitman, CHU de Martinique, Fort de France, Martinique, 4Rheumatology, Hopital Pierre Zobda Quitman, CHU de Martinique, Fort de France, Martinique

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: African-Americans, Ethnic studies, temporal arteritis and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Healthcare Disparities in Rheumatology Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Multiple epidemiological studies ascertained that GCA is one of the most common systemic vasculitis in western countries. But, there is only one study based on 2 patients in Tennessee to assess the low incidence of GCA in African descent (AD) populations. Moreover, very few series are devoted to these patients in the literature. Our objective was to describe the characteristics of GCA and study the incidence in the Afro-Caribbean (AC) population of Martinique, a French region of the West Indies where inhabitants are more than 90% of AD and have free access to health care including a regional competence center for systemic vasculitis.

Methods: Population based retrospective study in Martinique. Computed files of the 2 pathology units of the island (public and private) were analyzed to find all patients with a positive temporal arteritis biopsy. All medical files were reviewed to assess the incidence, but only AC patients (self-declared) were included to describe the disease in an African descent cohort.

Results: 40 patients had a biopsy proven GCA between 1991 and 2016. Mean age at GCA diagnosis was 75.7 years (SD±7.4; range: 63-91). Main manifestations at diagnosis of the 38 patients of AC origin (30 women, 8 men) were: fever 9.1% (3/33), asthenia 64.5% (20/31), weight loss 75.7% (25/33), headache 69.4% (25/36), jaw claudication 36.3% (12/33), scalp tenderness 35.2% (12/34), anterior ischemic optic neuropathy 31.4% (11/35), stroke 2.9% (1/34), and polymyalgia rheumatica 35.2% (12/34). C-reactive protein was over normal value for 96.8% (n=31; mean value 106.5, range: 7-283). ESR was positive in 86.3% (19/22). Available for 15 patients, CT scan of the aorta and its branches revealed one aortitis and one arteriopathy of lower limbs. All patients were treated by steroids. Twenty three patients (60.5%) were followed >18 months and mean follow up duration was 43.7 months. Eleven patients relapsed. Six patients died (15.8%). Kaplan Meier analysis found 93.9%, 84.6%, 75% survival rates at respectively 6, 12 and 24 months. Crude mean annual incidence of GCA in Martinique was 3.12 cases for 106 inhabitants from 1991 to 2016. Mean number of GCA gradually increased from 0.5 patient/year between 1991 and 2000, 1.6 between 2001 and 2010 to 3.8 between 2011 and 2016, parallel to the increasing proportion of elderly in the martinican population (13% was over 60 years old in 1990, 23% in 2016 and official estimation is 39.6% in 2032).

Conclusion: This is the first population based description of GCA in an AD population. The features in Martinique are similar to the literature, except for the ischemic complications that seem less frequent in our population. Our data confirm the low frequency of GCA in AD populations compared to Caucasians. The retrospective nature of the study and the absence of negative biopsy GCA could weaken conclusion. We note a progressive increase of annual number of cases during the 25 years of survey, parallel to the accelerated ageing of the martinican population. We could hypothesize that low incidence of GCA in AD populations is at least partially related to the low rate of elderly in most of these populations around the world, and could also increase in the future.


Disclosure: F. Moinet, None; V. Molinie, None; K. Polomat, None; H. Merle, None; M. Blettery, None; L. Brunier-Agot, None; M. DeBandt, None; C. Deligny, None.

To cite this abstract in AMA style:

Moinet F, Molinie V, Polomat K, Merle H, Blettery M, Brunier-Agot L, DeBandt M, Deligny C. Biopsy Proven Giant Cell Arteritis in African Descent Populations: Incidence and Characteristics in Martinique, French West Indies [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/biopsy-proven-giant-cell-arteritis-in-african-descent-populations-incidence-and-characteristics-in-martinique-french-west-indies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/biopsy-proven-giant-cell-arteritis-in-african-descent-populations-incidence-and-characteristics-in-martinique-french-west-indies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology